Adhesive and self-healing materials for central nervous system repair
Source abstract
Abstract
The central nervous system (CNS) has a limited ability to regenerate after a traumatic injury or a disease due to the low capacity of the neurons to re-grow and the inhibitory environment formed in situ. Current therapies include the use of drugs and rehabilitation, which do not fully restore the CNS functions and only delay the pathology progression. Tissue engineering offers a simple and versatile solution for this problem through the use of bioconstructs that promote nerve tissue repair by bridging cavity spaces. In this approach, the choice of biomaterial is crucial. Herein, we present recent advances in the design and development of adhesive and self-healing materials that support CNS healing. The adhesive materials have the advantage of promoting recovery without the use of needles or sewing, while the self-healing materials have the capacity to restore the tissue integrity without the need for external intervention. These materials can be used alone or in combination with cells and/or bioactive agents to control the inflammation, formation of free radicals, and proteases activity. We discuss the advantages and drawbacks of different systems. The remaining challenges that can bring these materials to clinical reality are also briefly presented.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Nerve injury and regeneration · Electrospun Nanofibers in Biomedical Applications · Wound Healing and Treatments
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (100+)
Show source-provided references
1. 2006 · 217
2. Current and novel polymeric biomaterials for neural tissue engineering10.1186/s12929-018-0491-8 ↗
3. Physical chitosan microhydrogels as scaffolds for spinal cord injury restoration and axon regeneration10.1016/j.biomaterials.2017.05.024 ↗
4. Biodegradable nanotopography combined with neurotrophic signals enhances contact guidance and neuronal differentiation of human neural stem cells10.1002/mabi.201500080 ↗
5. Biomaterials for revascularization and immunomodulation after spinal cord injury10.1088/1748-605X/aaa9d8 ↗
6. The far-reaching scope of neuroinflammation after traumatic brain injury10.1038/nrneurol.2017.13 ↗
7. Injectable hydrogels as novel materials for central nervous system regeneration10.1088/1741-2552/aacbab ↗
8. Hydrogels as scaffolds and delivery systems to enhance axonal regeneration after injuries10.3389/fncel.2015.00013 ↗
9. CNS sterile injury: just another wound healing?10.1016/j.molmed.2012.11.007 ↗
10. Adhesion molecule-modified biomaterials for neural tissue engineering10.3389/neuro.16.006.2009 ↗
11. Materials for central nervous system regeneration: bioactive cues10.1039/c0jm04335d ↗
12. A clinical practice guideline for the management of acute spinal cord injury: introduction, rationale, and scope10.1177/2192568217703387 ↗
13. Spinal cord injury: pathophysiology, treatment strategies, associated challenges, and future implications10.1007/s00441-019-03039-1 ↗
14. Neural stem cell therapy for cancer10.1016/j.ymeth.2015.08.013 ↗
15. Biomaterials used in stem cell therapy for spinal cord injury10.1016/j.pmatsci.2019.02.002 ↗
16. Old drugs as new treatments for neurodegenerative diseases10.3390/ph11020044 ↗
17. Clinical neurorestorative therapeutic guidelines for spinal cord injury (IANR/CANR version 2019)10.1016/j.jot.2019.10.006 ↗
18. Stem cell clinical trials in spinal cord injury: a brief review of studies in the United States
19. NG2+ progenitors derived from embryonic stem cells penetrate glial scar and promote axonal outgrowth into white matter after spinal cord injury10.5966/sctm.2014-0107 ↗
20. Filling the gap: neural stem cells as a promising therapy for spinal cord injury10.3390/ph12020065 ↗
21. Treatment of spinal cord injury with mesenchymal stem cells10.1186/s13578-020-00475-3 ↗
22. Schwann cell transplantation exerts neuroprotective roles in rat model of spinal cord injury by combating inflammasome activation and improving motor recovery and remyelination10.1007/s11011-019-00433-0 ↗
23. Astrocyte transplantation for repairing the injured spinal cord10.7555/JBR.36.20220012 ↗
24. Olfactory ensheathing cells for spinal cord injury: sniffing out the issues10.1177/0963689718779353 ↗
25. The link between olfactory ensheathing cell survival and spinal cord injury repair: a commentary on common limitations of contemporary research10.4103/1673-5374.280310 ↗
26. Myelinogenic plasticity of oligodendrocyte precursor cells following spinal cord contusion injury10.1523/JNEUROSCI.2409-16.2017 ↗
27. Regenerative therapies for spinal cord injury10.1089/ten.teb.2019.0182 ↗
28. An injectable, self-healing hydrogel to repair the central nervous system10.1002/adma.201500762 ↗
29. Soft biological materials and their impact on cell function10.1039/B610522J ↗
30. Mechanical characterization of human brain tissue10.1016/j.actbio.2016.10.036 ↗
31. Biomaterials for brain tissue engineering10.1071/CH10159 ↗
32. Mechanics in neuronal development and repair10.1146/annurev-bioeng-071811-150045 ↗
33. Role and prospects of regenerative biomaterials in the repair of spinal cord injury10.4103/1673-5374.253512 ↗
34. Tissue adhesives: from research to clinical translation10.1016/j.nantod.2020.101049 ↗
35. Injectable, adhesive, self-healing and conductive hydrogels based on MXene nanosheets for spinal cord injury repair10.1016/j.cej.2022.139252 ↗
36. Surface, interfacial and molecular aspects of polymer bioadhesion10.1016/0168-3659(85)90050-1 ↗
37. An investigation of the rheological behaviour10.1016/0378-5173(82)90025-4 ↗
38. Recent advances in tissue adhesives for clinical medicine10.3390/polym12040939 ↗
39. The recent progress of tissue adhesives in design strategies, adhesive mechanism and applications10.1016/j.msec.2020.110796 ↗
40. Mussel-inspired hydrogel tissue adhesives for wound closure10.1039/C7RA06743G ↗
41. Overcoming the translational barriers of tissue adhesives10.1038/s41578-019-0171-7 ↗
42. Cohesion mechanisms for bioadhesives
43. Mechanically reinforced catechol-containing hydrogels with improved tissue gluing performance10.3390/biomimetics2040023 ↗
44. An injectable and instant self-healing medical adhesive for wound sealing10.1021/acsami.0c01022 ↗
45. Mussel-inspired bioadhesives in healthcare: design parameters, current trends, and future perspectives10.1039/C9BM01848D ↗
46. Rational engineering and applications of functional bioadhesives in biomedical engineering10.1002/biot.202100231 ↗
47. Polymer composition and substrate influences on the adhesive bonding of a biomimetic, cross-linking polymer10.1021/ja303369p ↗
48. Cyanoacrylate in nerve repair: transient cytotoxic effect10.1016/j.ijom.2010.03.008 ↗
49. Zinc induced polyelectrolyte coacervate bioadhesive and its transition to a self-healing hydrogel10.1039/C5RA11915D ↗
50. Fibrin glue10.1016/0268-960X(91)90015-5 ↗
51. Polyethylene glycol hydrogel spinal sealant (DuraSeal Spinal Sealant) as an adjunct to sutured dural repair in the spine: results of a prospective, multicenter, randomized controlled study10.1097/BRS.0b013e3181fdb4db ↗
52. Dry double-sided tape for adhesion of wet tissues and devices10.1038/s41586-019-1710-5 ↗
53. High efficacy of tetra-PEG hydrogel sealants for sutureless dural closure
54. A dual-drug enhanced injectable hydrogel incorporated with neural stem cells for combination therapy in spinal cord injury10.1016/j.cej.2021.130906 ↗
55. Reconstruction of the spinal cord of spinal transected dogs with polyethylene glycol10.25259/SNI-73-2019 ↗
56. Degradable adhesives for surgery and tissue engineering10.1021/acs.biomac.7b00969 ↗
57. Histological effects of fibrin glue and synthetic tissue glues on the spinal cord: are they safe to use?10.1080/02688697.2017.1359491 ↗
58. Adhesive, stretchable, and spatiotemporal delivery fibrous hydrogels harness endogenous neural stem/progenitor cells for spinal cord injury repair10.1021/acsnano.1c06892 ↗
59. Mechanically stable fibrin scaffolds promote viability and induce neurite outgrowth in neural aggregates derived from human induced pluripotent stem cells10.1038/s41598-017-06570-9 ↗
60. A dual-enzymatically cross-linked injectable gelatin hydrogel loaded with BMSC improves neurological function recovery of traumatic brain injury in rats10.1039/C9BM00749K ↗
61. In situ forming gelatin hydrogels by dual-enzymatic cross-linking for enhanced tissue adhesiveness10.1039/C6TB02179D ↗
62. Modification and crosslinking of gelatin-based biomaterials as tissue adhesives10.1016/j.colsurfb.2018.10.077 ↗
63. Influence of gelatin cues in PCL electrospun membranes on nerve outgrowth10.1021/bm100221h ↗
64. Optimization of fully aligned bioactive electrospun fibers for "in vitro" nerve guidance10.1007/s10856-014-5214-4 ↗
65. PCL/gelatin nanofibrous scaffolds with human endometrial stem cells/Schwann cells facilitate axon regeneration in spinal cord injury10.1002/jcp.27936 ↗
66. Synergistic effects of gelatin and nanotopographical patterns on biomedical PCL patches for enhanced mechanical and adhesion properties
67. A conductive supramolecular hydrogel creates ideal endogenous niches to promote spinal cord injury repair
68. Fibrin scaffolds embedded with sonic hedgehog/chitosan microspheres for recovery of spinal cord injury in rats10.1166/mex.2020.1654 ↗
69. Study on physical properties and nerve cell affinity of composite films from chitosan and gelatin solutions10.1016/S0142-9612(03)00117-0 ↗
70. Intranasal piperine-loaded chitosan nanoparticles as brain-targeted therapy in Alzheimer's disease: optimization, biological efficacy, and potential toxicity10.1002/jps.24557 ↗
71. Venlafaxine loaded chitosan NPs for brain targeting: pharmacokinetic and pharmacodynamic evaluation10.1016/j.carbpol.2012.02.051 ↗
72. Novel luteolin-loaded chitosan decorated nanoparticles for brain-targeting delivery in a sporadic Alzheimer's disease mouse model: focus on antioxidant, anti-inflammatory, and amyloidogenic pathways10.3390/pharmaceutics14051003 ↗
73. Kaempferol-loaded mucoadhesive nanoemulsion for intranasal administration reduces glioma growth in vitro10.1016/j.ijpharm.2018.03.055 ↗
74. Inhibition of astrocytic differentiation of transplanted neural stem cells by chondroitin sulfate methacrylate hydrogels for the repair of injured spinal cord10.1039/C8BM01363B ↗
75. Fibrin sealant: the only approved hemostat, sealant, and adhesive-a laboratory and clinical perspective10.1155/2014/203943 ↗
76. Fibrin sealants in dura sealing: a systematic literature review10.1371/journal.pone.0151533 ↗
77. Application of fibrin-based hydrogels for nerve protection and regeneration after spinal cord injury10.1186/s13036-020-00244-3 ↗
78. Genipin-crosslinked fibrin seeded with oxidized alginate microbeads as a novel composite biomaterial strategy for intervertebral disc cell therapy10.1016/j.biomaterials.2022.121641 ↗
79. Structural and chemical modification to improve adhesive and material properties of fibrin-genipin for repair of annulus fibrosus defects in intervertebral disks10.1115/1.4036623 ↗
80. A review: gelatine as a bioadhesive material for medical and pharmaceutical applications10.1016/j.ijpharm.2021.121037 ↗
81. Agarose-based biomaterials for tissue engineering10.1016/j.carbpol.2018.01.060 ↗
82. Chitosan based bioactive materials in tissue engineering applications-a review
83. Cell-seeded porous silk fibroin scaffolds promotes axonal regeneration and myelination in spinal cord injury rats10.1016/j.bbrc.2019.04.137 ↗
84. Mahira · 2019 · 1
85. Sutureless nerve repair with laser-activated chitosan adhesive: a pilot in vivo study10.1089/pho.2007.2131 ↗
86. The use of chitosan-based scaffolds to enhance regeneration in the nervous system10.1016/B978-0-12-420045-6.00001-8 ↗
87. Application of a novel film sealant Technology for Penetrating Corneal Wounds: an ex-vivo study10.3390/app10093193 ↗
88. Mollusk glue inspired mucoadhesives for biomedical applications10.1021/la3025414 ↗
89. Chitosan-based nanocarriers for nose to brain delivery10.3390/app9112219 ↗
90. Multiple roles of chitosan in mucosal drug delivery: an updated review10.3390/md20050335 ↗
91. Potential of chitosan and its derivatives for biomedical applications in the central nervous system10.3389/fbioe.2020.00389 ↗
92. Biomaterial scaffolds in regenerative therapy of the central nervous system
93. Nasal delivery of donepezil HCl-loaded hydrogels for the treatment of Alzheimer's disease10.1038/s41598-019-46032-y ↗
94. Chondroitin sulfates and their binding molecules in the central nervous system10.1007/s10719-017-9761-z ↗
95. The role of chondroitin sulfate proteoglycans in nervous system development10.1369/0022155420959147 ↗
96. Combinatorial therapies after spinal cord injury: how can biomaterials help?10.1002/adhm.201601130 ↗
97. A versatile pH sensitive chondroitin sulfate-PEG tissue adhesive and hydrogel10.1016/j.biomaterials.2009.12.033 ↗
98. Mussel-inspired hydrogels: from design principles to promising applications10.1039/C9CS00849G ↗
99. Adhesive, conductive, self-healing, and antibacterial hydrogel based on chitosan-polyoxometalate complexes for wearable strain sensor10.1021/acsapm.0c00150 ↗
100. Recent approaches in designing bioadhesive materials inspired by mussel adhesive protein10.1002/pola.28368 ↗